Identification of Astragalus Polysaccharide as a Neuroprotective Agent via Activating Klotho-mediated Nrf2 Pathway
Kuo Liu1, Nannan Ding1, Mengying Han2, Shuping Shen2, Lin Li2, Fang Bian1, Li Chen1, Ji Zhang1, Lailiang Qu3, Dan Yang1★★ Corresponding author
- 1Department of Pharmacy, Featured Preparations of Vitiligo Xiangyang Key Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, CHINA.
- 2College of Life Sciences, Xinyang Normal University, Tea Plant Biology Key Laboratory of Henan Province, Xinyang, Henan, CHINA.
- 3College of Medicine, Xinyang Normal University, Xinyang, Henan, CHINA.
CORRESPONDENCE
Dan Yang
Department of Pharmacy, Featured Preparations of Vitiligo Xiangyang Key Laboratory, Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, Hubei, CHINA.
Received: 06-04-2024; Accepted: 18-07-2024.
Volume 21, Issue 1 · pp. 161–169 · PUBLISHED 2025 · DOI: 10.1177/09731296241279103
View on Pharmacogn. Mag. original site ↗
ABSTRACT
Background: Neurodegenerative diseases (NDs) have become a significant public health problem, and oxidative stress (OS) serves as a pivotal factor in the pathological progression of NDs. Pharmacological research indicates that Astragalus polysaccharide (APS, extract of Astragalus membranaceus) has antioxidant and antiaging effects, closely related to NDs. Objectives: The potential of APS in treating NDs remains uncertain. Herein, the neuroprotective effect of APS was evaluated. Materials and Methods: The H2O2-induced PC12 cell damage model was established to assess the neuroprotection of APS. Cell viability was determined by MTT. Cell images were observed using ImageXpress Micro Confocal analysis. Apoptosis of the cells and intracellular levels of reactive oxygen species (ROS) were detected using flow cytometry. The expression of Klotho, nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase-1 (HO-1), thioredoxin reductase 1 (TrxR1), and NAD(P)H quinone oxidoreductase 1 (NQO1) was determined by Western blot (WB). Results: APS exerted significant protection against H2O2-caused cell death dose-dependently, and APS could significantly reduce the intracellular ROS and relieve cell apoptosis. Furthermore, we found that APS could upregulate the expression of Klotho and Nrf2 dose-dependently, and the expression levels of Nrf2-mediated antioxidant proteins increased significantly, including HO-1, TrxR1, and NQO1. Moreover, we found that APS upregulated Klotho and Nrf2-mediated antioxidant proteins time-dependently. The expression of klotho peaked at 6 hours after treatment with APS (400 mg/L). Subsequently, the protein level of Nrf2 reached the maximum at 12 hours, and the downstream NQO1, HO-1, and TrxR1 levels peaked at 24 hours. Conclusion: This study demonstrates that APS is promising for further development against oxidative stress-related NDs.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Liu, K., Ding, N., Han, M., Shen, S., Li, L., Bian, F., Chen, L., Zhang, J., Qu, L., & Yang, D. (2025). Identification of Astragalus Polysaccharide as a Neuroprotective Agent via Activating Klotho-mediated Nrf2 Pathway. Pharmacognosy Magazine, 21(1), 161–169. https://doi.org/10.1177/09731296241279103
